revealed a nonenzymatic mechanism of PRDX6‐mediated tumor promotion, wherein PRDX6 prevents the ubiquitination and degradation of nicotinamide N‐methyltransferase (NNMT), thereby activating the MAPK signaling pathway and facilitating ovarian cancer progression [25]. The gene discussed is PRDX6; the disease is neoplasm.